Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Protalix BioTherapeutics, Inc. stock logo
PLX
Protalix BioTherapeutics
$1.20
+1.7%
$1.35
$1.09
$3.55
$86.20M0.88338,276 shs272,095 shs
Shift Technologies, Inc. stock logo
SFT
Shift Technologies
$0.99
$0.10
$5.90
$2.90M1.581.81 million shs178.35 million shs
SPK Acquisition Corp. stock logo
SPK
SPK Acquisition
$10.30
$10.22
$9.84
$10.68
$67.94M-0.0112,839 shs33,515 shs
WesCan Energy Corp. stock logo
WCE
WesCan Energy
C$0.05
C$0.05
C$0.04
C$0.11
C$2.07M0.0578,995 shs1,000 shs
(Almost) Everything You Need To Know About The EV Market Cover

Click the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Protalix BioTherapeutics, Inc. stock logo
PLX
Protalix BioTherapeutics
+1.69%+3.90%-5.51%-18.37%-51.42%
Shift Technologies, Inc. stock logo
SFT
Shift Technologies
0.00%0.00%0.00%0.00%-88.01%
SPK Acquisition Corp. stock logo
SPK
SPK Acquisition
0.00%0.00%0.00%0.00%0.00%
WesCan Energy Corp. stock logo
WCE
WesCan Energy
0.00%0.00%+11.11%0.00%-23.08%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Protalix BioTherapeutics, Inc. stock logo
PLX
Protalix BioTherapeutics
2.4769 of 5 stars
3.50.00.00.00.60.03.1
Shift Technologies, Inc. stock logo
SFT
Shift Technologies
N/AN/AN/AN/AN/AN/AN/AN/A
SPK Acquisition Corp. stock logo
SPK
SPK Acquisition
N/AN/AN/AN/AN/AN/AN/AN/A
WesCan Energy Corp. stock logo
WCE
WesCan Energy
N/AN/AN/AN/AN/AN/AN/AN/A

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Protalix BioTherapeutics, Inc. stock logo
PLX
Protalix BioTherapeutics
3.00
Buy$10.00733.33% Upside
Shift Technologies, Inc. stock logo
SFT
Shift Technologies
N/AN/AN/AN/A
SPK Acquisition Corp. stock logo
SPK
SPK Acquisition
N/AN/AN/AN/A
WesCan Energy Corp. stock logo
WCE
WesCan Energy
N/AN/AN/AN/A

Current Analyst Ratings

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Protalix BioTherapeutics, Inc. stock logo
PLX
Protalix BioTherapeutics
$65.49M1.34$0.14 per share8.65$0.47 per share2.55
Shift Technologies, Inc. stock logo
SFT
Shift Technologies
$328.81M0.00N/AN/A($3.47) per share0.00
SPK Acquisition Corp. stock logo
SPK
SPK Acquisition
N/AN/AN/AN/A($0.19) per shareN/A
WesCan Energy Corp. stock logo
WCE
WesCan Energy
C$2.69M0.77C$0.01 per share7.50C$0.04 per share1.25

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Protalix BioTherapeutics, Inc. stock logo
PLX
Protalix BioTherapeutics
$8.31M$0.0524.001.48N/A12.69%29.73%10.17%5/2/2024 (Estimated)
Shift Technologies, Inc. stock logo
SFT
Shift Technologies
-$172.04M-$12.31N/AN/AN/A-41.12%N/A-90.54%N/A
SPK Acquisition Corp. stock logo
SPK
SPK Acquisition
-$420KN/A0.00N/AN/AN/A-1.95%N/A
WesCan Energy Corp. stock logo
WCE
WesCan Energy
N/AN/AN/AN/A10.26%15.40%0.54%N/A

Latest SFT, WCE, NUOG, SPK, and PLX Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
3/14/2024Q4 2023
Protalix BioTherapeutics, Inc. stock logo
PLX
Protalix BioTherapeutics
-$0.03-$0.07-$0.04-$0.07$8.15 million$10.49 million    

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Protalix BioTherapeutics, Inc. stock logo
PLX
Protalix BioTherapeutics
N/AN/AN/AN/AN/A
Shift Technologies, Inc. stock logo
SFT
Shift Technologies
N/AN/AN/AN/AN/A
SPK Acquisition Corp. stock logo
SPK
SPK Acquisition
N/AN/AN/AN/AN/A
WesCan Energy Corp. stock logo
WCE
WesCan Energy
N/AN/AN/AN/AN/A

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Protalix BioTherapeutics, Inc. stock logo
PLX
Protalix BioTherapeutics
N/A
1.54
1.12
Shift Technologies, Inc. stock logo
SFT
Shift Technologies
N/A
1.33
0.92
SPK Acquisition Corp. stock logo
SPK
SPK Acquisition
N/A
4.64
4.64
WesCan Energy Corp. stock logo
WCE
WesCan Energy
113.63
0.12
0.46

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Protalix BioTherapeutics, Inc. stock logo
PLX
Protalix BioTherapeutics
16.53%
Shift Technologies, Inc. stock logo
SFT
Shift Technologies
11.34%
SPK Acquisition Corp. stock logo
SPK
SPK Acquisition
19.64%
WesCan Energy Corp. stock logo
WCE
WesCan Energy
N/A

Insider Ownership

CompanyInsider Ownership
Protalix BioTherapeutics, Inc. stock logo
PLX
Protalix BioTherapeutics
4.97%
Shift Technologies, Inc. stock logo
SFT
Shift Technologies
11.40%
SPK Acquisition Corp. stock logo
SPK
SPK Acquisition
22.40%
WesCan Energy Corp. stock logo
WCE
WesCan Energy
29.57%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Protalix BioTherapeutics, Inc. stock logo
PLX
Protalix BioTherapeutics
20873.05 million69.42 millionOptionable
Shift Technologies, Inc. stock logo
SFT
Shift Technologies
46417.00 million15.06 millionOptionable
SPK Acquisition Corp. stock logo
SPK
SPK Acquisition
2,0216.60 million5.12 millionNot Optionable
WesCan Energy Corp. stock logo
WCE
WesCan Energy
N/A41.47 millionN/ANot Optionable

SFT, WCE, NUOG, SPK, and PLX Headlines

SourceHeadline
Wescan Goldfields Inc. (WGF.V)Wescan Goldfields Inc. (WGF.V)
ca.finance.yahoo.com - April 16 at 3:46 PM
Wescan Energy Corp WCEWescan Energy Corp WCE
morningstar.com - March 16 at 6:51 PM
Declining Stock and Solid Fundamentals: Is The Market Wrong About WesCan Energy Corp. (CVE:WCE)?Declining Stock and Solid Fundamentals: Is The Market Wrong About WesCan Energy Corp. (CVE:WCE)?
finance.yahoo.com - March 2 at 12:35 PM
WesCan Energy Announces Results of AGMWesCan Energy Announces Results of AGM
finance.yahoo.com - September 29 at 12:38 PM
WesCan Energy Corp: WesCan Energy Announces Resignation of Chief Executive OfficerWesCan Energy Corp: WesCan Energy Announces Resignation of Chief Executive Officer
finanznachrichten.de - September 27 at 4:33 AM
WesCan Energy announces resignation of Chief Executive OfficerWesCan Energy announces resignation of Chief Executive Officer
boereport.com - September 27 at 4:33 AM
The Compensation For WesCan Energy Corp.s (CVE:WCE) CEO Looks Deserved And Heres WhyThe Compensation For WesCan Energy Corp.'s (CVE:WCE) CEO Looks Deserved And Here's Why
finance.yahoo.com - September 22 at 9:42 AM
Closing Bell: Wescan Energy Corp up on Wednesday (WCE)Closing Bell: Wescan Energy Corp up on Wednesday (WCE)
theglobeandmail.com - August 24 at 11:54 PM
Closing Bell: Wescan Energy Corp up on Thursday (WCE)Closing Bell: Wescan Energy Corp up on Thursday (WCE)
theglobeandmail.com - August 24 at 6:54 PM
Canadian Investment Regulatory Organization Trade Resumption - WCECanadian Investment Regulatory Organization Trade Resumption - WCE
finance.yahoo.com - August 22 at 6:35 PM
Closing Bell: Wescan Energy Corp flat on Tuesday (WCE)Closing Bell: Wescan Energy Corp flat on Tuesday (WCE)
theglobeandmail.com - August 15 at 2:32 AM
Canadian Investment Regulatory Organization Trading Halt - WCECanadian Investment Regulatory Organization Trading Halt - WCE
finance.yahoo.com - August 9 at 8:22 AM
Closing Bell: Wescan Energy Corp flat on Thursday (WCE)Closing Bell: Wescan Energy Corp flat on Thursday (WCE)
theglobeandmail.com - August 4 at 8:02 PM
Closing Bell: Wescan Energy Corp up on Friday (WCE)Closing Bell: Wescan Energy Corp up on Friday (WCE)
theglobeandmail.com - July 29 at 8:41 AM
Should Weakness in WesCan Energy Corp.s (CVE:WCE) Stock Be Seen As A Sign That Market Will Correct The Share Price Given Decent Financials?Should Weakness in WesCan Energy Corp.'s (CVE:WCE) Stock Be Seen As A Sign That Market Will Correct The Share Price Given Decent Financials?
finance.yahoo.com - May 23 at 8:52 AM
Closing Bell: Wescan Energy Corp down on Friday (WCE)Closing Bell: Wescan Energy Corp down on Friday (WCE)
theglobeandmail.com - May 20 at 2:43 PM
Closing Bell: Wescan Energy Corp up on Tuesday (WCE)Closing Bell: Wescan Energy Corp up on Tuesday (WCE)
theglobeandmail.com - May 17 at 4:14 PM
Closing Bell: Wescan Energy Corp down on Monday (WCE)Closing Bell: Wescan Energy Corp down on Monday (WCE)
theglobeandmail.com - May 2 at 12:52 PM
Closing Bell: Wescan Energy Corp down on Wednesday (WCE)Closing Bell: Wescan Energy Corp down on Wednesday (WCE)
theglobeandmail.com - April 26 at 11:52 PM
WesCan Energy Corp. (WCE.V)WesCan Energy Corp. (WCE.V)
finance.yahoo.com - April 15 at 8:22 AM
Closing Bell: Wescan Energy Corp up on Monday (WCE)Closing Bell: Wescan Energy Corp up on Monday (WCE)
theglobeandmail.com - April 12 at 10:52 AM
WesCan Energy Corp (WCE) NPVWesCan Energy Corp (WCE) NPV
hl.co.uk - April 7 at 5:34 PM
Closing Bell: Wescan Energy Corp flat on Wednesday (WCE)Closing Bell: Wescan Energy Corp flat on Wednesday (WCE)
theglobeandmail.com - April 6 at 6:10 PM
WesCan Energy Acquires Additional Lands at ProvostWesCan Energy Acquires Additional Lands at Provost
finance.yahoo.com - February 13 at 2:21 PM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

All Headlines

Company Descriptions

Protalix BioTherapeutics logo

Protalix BioTherapeutics

NYSE:PLX
Protalix BioTherapeutics, Inc., a biopharmaceutical company, engages in the development, production, and commercialization of recombinant therapeutic proteins based on its proprietary ProCellEx plant cell-based protein expression system in the United States, Australia, Canada, Israel, Brazil, Russia, Turkey, and internationally. The company offers Elelyso for the treatment of Gaucher disease; and Elfabrio for the treatment of adult patients with a confirmed diagnosis of Fabry disease. It is also developing PRX-115, a plant cell-expressed recombinant PEGylated Uricase which is in Phase I trial for the treatment of gout; and PRX-119, a plant cell-expressed PEGylated recombinant human DNase I product candidate that is in preclinical phase for the treatment of NETs-related diseases. The company has agreements and partnerships with Pfizer; Fundação Oswaldo Cruz; and Chiesi Farmaceutici S.p.A. The company was incorporated in 1993 and is headquartered in Karmiel, Israel. Protalix BioTherapeutics, Inc. is a subsidiary of Protalix Ltd.
Shift Technologies logo

Shift Technologies

NASDAQ:SFT
Shift Technologies, Inc., together with its subsidiaries, provides an ecommerce platform for buying and selling used cars in the United States. The company operates in two segments, Retail and Wholesale. It engages in the retail sale of used vehicles through its platform; and provides financing and vehicle protection products. The company also provides value-added products, such as vehicle service contracts, guaranteed asset protection waiver coverage, wheel and tire coverage, prepaid maintenance plans, and appearance protection plans. In addition, it is involved in the sale of used vehicles through wholesale auctions or directly to a wholesaler. The company was founded in 2013 and is headquartered in San Francisco, California.
SPK Acquisition logo

SPK Acquisition

NASDAQ:SPK
SPK Acquisition Corp. intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. It intends to focus on operating businesses in the telecommunications, media, and technology sectors in Asia. The company was incorporated in 2020 and is based in Shanghai, China.
WesCan Energy logo

WesCan Energy

CVE:WCE
WesCan Energy Corp., a junior public resource company, explores for, develops, and produces oil and gas properties in Alberta, Canada; and Texas, the United States. It holds interests in petroleum and natural gas assets located in Alberta. The company was formerly known as Great Pacific International Inc. and changed its name to WesCan Energy Corp. in October 2012. WesCan Energy Corp. was incorporated in 1993 and is headquartered in Calgary, Canada.